Andrea Napolitano, Karla V. Ballman, Mark Agulnik, Seth M. Pollack, Sandra P. D'Angelo. "SARC045: A phase 2 trial of tebentafusp in HLA-A*02:01–positive patients with advanced clear cell sarcoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps11591